PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $342,000 | -23.0% | 33,372 | -21.7% | 0.03% | -39.1% |
| Q2 2020 | $444,000 | -87.6% | 42,643 | +42.1% | 0.05% | +12.2% |
| Q3 2017 | $3,592,000 | -48.2% | 30,000 | -62.2% | 0.04% | -60.6% |
| Q2 2017 | $6,939,000 | +1532.7% | 79,400 | +455.2% | 0.10% | +420.0% |
| Q2 2016 | $425,000 | -15.3% | 14,300 | +232.6% | 0.02% | -73.7% |
| Q2 2015 | $502,000 | – | 4,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |